Pub. Date : 2016
PMID : 26642078
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The PARADIGM-HF study, a large outcome trial in heart failure and reduced ejection fraction (HFrEF), has recently shown improved cardiovascular outcomes with sacubitril/valsartan (Entresto , Novartis), still commonly referred to as LCZ696, compared to ACE-inhibitor therapy, possibly leading us to a new era for heart failure (HF) treatment. | Valsartan | angiotensin I converting enzyme | Homo sapiens |